Bnt 疫苗. On the basis of reactogenicity and. During the phase 1 study, a total of 48 children 5 to 11 years of age received 10 μg, 20 μg, or 30 μg of the bnt162b2 vaccine (16 children at each dose level).
During the phase 1 study, a total of 48 children 5 to 11 years of age received 10 μg, 20 μg, or 30 μg of the bnt162b2 vaccine (16 children at each dose level). Every product is the result of 1,500 scientists overseeing more than 500,000 lab tests and over 36 clinical trials before the first prescription. On the basis of reactogenicity and.
BNT疫苗快來了？ 傳一週內將有100多萬劑抵台
On the basis of reactogenicity and. During the phase 1 study, a total of 48 children 5 to 11 years of age received 10 μg, 20 μg, or 30 μg of the bnt162b2 vaccine (16 children at each dose level). On the basis of reactogenicity and. Every product is the result of 1,500 scientists overseeing more than 500,000 lab tests and over 36 clinical trials before the first prescription.
